Free Shipping on All Orders Above $150!
Free Shipping on All Orders Above $150!
Thymosin Alpha-1 (Tα1) is a synthetic peptide corresponding to a naturally occurring fragment derived from prothymosin alpha. Extensively studied for its immunomodulatory properties, Tα1 has demonstrated potential in enhancing T-cell function, regulating immune responses, and exhibiting antiviral and anticancer activities. Research has explored its applications in conditions such as chronic infections, cancer, and immunodeficiency disorders. Thymosin Alpha-1 is provided in lyophilized powder form for laboratory research purposes only.
$48.00
9 in stock
Free Shipping on orders over $150
Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from thymic tissue. It plays a crucial role in the maturation and differentiation of T-cells, essential components of the adaptive immune system. By modulating immune responses, Tα1 has been the subject of extensive research into its potential therapeutic applications, particularly in enhancing host defense mechanisms against infections and malignancies. This peptide is intended exclusively for scientific investigation and is not approved for human or veterinary use.
Thymosin Alpha-1 has been extensively studied for its role in enhancing cell-mediated immunity. It functions as an agonist for toll-like receptors, thereby stimulating antigen-presenting cells and promoting T-cell differentiation and activation. This modulation of the immune system has been explored in various research contexts, including vaccine adjuvants and immune deficiencies.
Research has investigated the potential of Thymosin Alpha-1 in the management of chronic hepatitis B and C infections. Studies suggest that Tα1 may enhance antiviral immune responses, potentially leading to improved viral clearance rates. Its immunomodulatory effects have been evaluated as monotherapy and in combination with standard antiviral treatments.
Thymosin Alpha-1 has been studied for its potential role in HIV infection, particularly in enhancing immune function. Research indicates that Tα1 may improve T-cell counts and function, suggesting a possible adjunctive role in HIV management. However, further studies are needed to establish its efficacy and safety in this context.
Thymosin Alpha-1 has been investigated for its potential anticancer properties. In vitro and in vivo studies suggest that Tα1 may inhibit tumor cell proliferation and enhance immune-mediated tumor suppression. Clinical research has explored its use as an adjunct to chemotherapy and immunotherapy in various malignancies.
Research has explored the potential benefits of Thymosin Alpha-1 in cystic fibrosis, particularly regarding its immunomodulatory effects and potential to reduce pulmonary infections. Studies suggest that Tα1 may enhance immune responses, potentially improving clinical outcomes in cystic fibrosis patients.
Ongoing research continues to explore the diverse applications of Thymosin Alpha-1 in immunology, oncology, and infectious diseases. Future studies aim to elucidate its mechanisms of action, optimize therapeutic protocols, and expand its potential clinical applications. The versatility of Tα1 as an immunomodulator positions it as a promising candidate for further investigation in various medical fields.
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Semer vel urna potet ipsum interdum adipiscing suscipit.
Explore our pharmaceutical-grade peptides for Research purpose. Quality tested, fast shipping, and made in the USA.
Get exclusive offers and the latest product updates delivered straight to your inbox, subscribe to our newsletter today!
© 2025 Wellness Peptides. All rights reserved.
All peptides sold by Wellness Peptides are for research purposes only and are not intended for human or veterinary use. Please ensure compliance with local regulations before ordering.